Abstract
According to the Centers for Disease Control and Prevention (CDC), it is estimated that 89,000 women in the United States are diagnosed with a gynecologic cancer annually [1]. It is estimated that over a million new cases and half million deaths are due to gynecological cancers occurring annually worldwide (Minig et al., Front Oncol 5:308, 2016). These cancers include ovarian, uterine, fallopian tube, cervical, vulvar, and vaginal. Surgical management involves a combination of tumor cytoreduction, hysterectomy, bilateral or single salpingo-oophorectomy, cervical conization, vulvectomy, wide local excision, lymphadenectomy, omentectomy, pelvic exenteration, laser, and radiation treatment. Surgical techniques include an open abdomen, laparoscopic, and robotic laparoscopic approach. Each different type of surgery poses different challenges to the surgical, medical, and anesthesia providers. Current literature supports the use of the enhanced recovery pathways (ERP), also called enhanced recovery after surgery (ERAS). The goal of the pathway is to hasten surgical recovery and decrease the stress response through a team approach. Common ERP interventions include oral fluids and carbohydrate supplements up to 2 h prior to surgery, euvolemia, postoperative nausea/vomiting prophylaxis, early oral nutrition, and ambulation on first surgical day. Enhanced recovery after surgery minimizes the use of traditional care such as nasogastric tubes, bowel preparations, NPO after midnight, and excessive intravenous opioids (Nelson et al., Gynecol Oncol 35(3):586–594, 2014). Anesthesia teams require knowledge in using ERAS protocols in conjunction with a variety of medications and techniques. Enhanced recovery pathways are shown to reduce hospital stay and cost and are considered a standard of care for gynecological surgical patients at some hospitals [17]. The purpose of this chapter is to examine current data related to anesthetic management of patients undergoing surgery for gynecological malignancies and provide an overview of postoperative management.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Cancer Society. Survival rates for ovarian cancer by stage. 2018. Retrieved 16 July 2018 https://www.cancer.org/cancer/ovarian-cancer/detection-diagnosis-staging/survival-rates.html
Asher R, Obermair A, Janda M, Gebski V. Disease-free and survival outcomes for total laparoscopic hysterectomy compared with total abdominal hysterectomy in early-stage endometrial carcinoma: a meta-analysis. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc. 2018;28(3):529–38. https://doi.org/10.1097/IGC.0000000000001199.
Binder PS, Prat J, Mutch DG. Molecular staging of gynecological cancer: what is the future? Best Pract Res Clin Obstet Gynaecol. 2015;29(6):776–89. https://doi.org/10.1016/j.bpobgyn.2015.01.008.
Brinton LA, Thistle JE, Liao LM, Trabert B. Epidemiology of vulvar neoplasia in the NIH-AARP study. Gynecol Oncol. 2017;145(2):298–304. https://doi.org/10.1016/j.ygyno.2017.02.030.
Centers for Disease Control and Prevention. Gynecologic cancers. 2018. Retrieved https://www.cdc.gov/cancer/gynecologic/index.htm
Estridge P, Akoh JA. Recurrent spontaneous pneumoperitoneum: a surgical dilemma. Int J Surg Case Rep. 2017;30:103–5.
Han LY, Slomovitz BM, Soliman PT, Wolf JK. Gynecologic cancers. In: Feig BW, Ching CD, editors. The M.D. Anderson surgical oncology handbook. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2012. p. 478–509.
Joshi GP. Anesthesia for laparoscopic and abdominal robotic surgery in adults. 2017. Retrieved 5 July 2018 www.uptodate.com
Karaman T, Ozsoy AZ, Karaman S, Dogru S, Tapar H, Sahin A, et al. The effects of transversus abdominis plane block on analgesic and anesthetic consumption during total abdominal hysterectomy: a randomized controlled study. [Efeitos do bloqueio do plano transverso abdominal sobre o consumo de analgesico e anestesico durante histerectomia abdominal total: um estudo randomico e controlado]. Rev Bras Anestesiol. 2018;68:285–91.
Kumar K, Kirksey MA, Duong S, Wu CL. A review of opioid-sparing modalities in perioperative pain management: methods to decrease opioid use postoperatively. Anesth Analg. 2017;125(5):1749–60.
Lasala JD, Mena GE, Rodriguez-Restrepo A, Iniesta MD, Corzo C, Meyer LA, et al. Implementation of an enhanced recovery after surgery (ERAS) program in gynecologic surgery: the role of the anesthesiologist in opioid sparing. Clin Nutr ESPEN. 2017;19:81.
Lee CL, Kusunoki S, Huang CY, Wu KY, Lee PS, Huang KG. Surgical and survival outcomes of laparoscopic staging surgery for patients with stage I ovarian cancer. Taiwan J Obstet Gynecol. 2018;57(1):7–12. https://doi.org/10.1016/j.tjog.2017.12.002.
Minig L, Padilla-Iserte P, Zorrero C. The relevance of gynecologic oncologists to provide high-quality of care to women with gynecological cancer. Front Oncol. 2016;5:308.
Miralpeix E, Nick AM, Meyer LA, Cata J, Lasala J, Mena GE, et al. A call for new standard of care in perioperative gynecologic oncology practice: impact of enhanced recovery after surgery (ERAS) programs. Gynecol Oncol. 2016;141(2):371–8. https://doi.org/10.1016/j.ygyno.2016.02.019. Epub 2016 Mar 9.
Nelson G, Dowdy SC, Lasala J, Mena G, Bakkum-Gamez J, Meyer LA, et al. Enhanced recovery after surgery (ERAS(R)) in gynecologic oncology - practical considerations for program development. Gynecol Oncol. 2017;147(3):617–20.
Nelson G, Kalogera E, Dowdy SC. Enhanced recovery pathways in gynecologic oncology. Gynecol Oncol. 2014;135(3):586–94. https://doi.org/10.1016/j.ygyno.2014.10.006.
Oliveira CRD, Bernardo WM, Nunes VM. Benefit of general anesthesia monitored by bispectral index compared with monitoring guided only by clinical parameters. Systematic review and meta-analysis. Rev Bras Anestesiol. 2017;67(1):72–84.
Panchgar V, Shetti AN, Sunitha HB, Dhulkhed VK, Nadkarni AV. The effectiveness of intravenous dexmedetomidine on perioperative hemodynamics, analgesic requirement, and side effects profile in patients undergoing laparoscopic surgery under general anesthesia. Anesth Essays Res. 2017;11(1):72–7. https://doi.org/10.4103/0259-1162.200232.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. https://doi.org/10.3322/caac.21442.
Standards for Basic Anesthetic Monitoring. Committee of Origin: Standards and Practice Parameters (Approved by the ASA House of Delegates on October 21, 1986, last amended on October 20, 2010, and last affirmed on October 28, 2016) https://www.asahq.org/~/media/Sites/ASAHQ/Files/Public/Resources/standards-guidelines/standards-forbasic-anesthetic-monitoring.pdf (Accessed on May 06, 2019)
Vapiwala N, Hill-Kayser C. All about fallopian tube cancer. Retrieved Oct 2018 https://www.oncolink.org/cancers/gynecologic/information-about-gynecologic-cancers/fallopian-tube-cancer/all-about-fallopian-tube-cancer
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Brydges, N., Boyko, L., Lasala, J.D. (2020). Total Abdominal Hysterectomy, Bilateral Salpingo-oophorectomy, and Pelvic Lymphadenectomy in Cancer Patients. In: Nates, J., Price, K. (eds) Oncologic Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-74588-6_184
Download citation
DOI: https://doi.org/10.1007/978-3-319-74588-6_184
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74587-9
Online ISBN: 978-3-319-74588-6
eBook Packages: MedicineReference Module Medicine